In DepthEpidemiology

For chronic fatigue syndrome, a ‘shifting tide’ at NIH

See allHide authors and affiliations

Science  11 Nov 2016:
Vol. 354, Issue 6313, pp. 691-692
DOI: 10.1126/science.354.6313.691

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Enter the characters shown in the image.

Vertical Tabs

  • RE: Chronic fatigue syndrome
    • Silvio Pitlik, Physician, Weizmann Institute of Science, Rehovot, Israel
    • Other Contributors:
      • Nina Pitlik, Pharmacologist, The Academic College of Tel Aviv-Yaffo

    At some point in time the NIH will have to delineate the boundaries for funding research of a ”mysterious illness” which is probably a disease of mind with no viral etiology, no auto-immune mechanisms or no effective drug therapy. To our modest opinion, efforts should concentrate on defining the best life style modifiers and types of emotional support to be given by health-care professionals and family members. In addition, we propose to eliminate the frightening, unsupported and deleterious term “encephalomyelitis” from the title for this condition.

    Competing Interests: None declared.